Abstract
Context: Clinical symptoms of Brunner’s gland (BG) hamartoma are rare. Most lesions are small and asymptomatic. Symptomatic BG hamartoma may mimic a malignancy of the duodenal-pancreatic area. Though standard mucosal biopsies are inferiorly diagnostic due to normal duodenal mucosa surrounding, a biopsy was indicated in this case. Case Report: We report the case of a 37-year-old man with a large BG hamartoma mimicking a malignancy. Preoperatively the biopsy led to an inconclusive diagnosis. Due to its large size and its presence of symptoms, a surgical excision was performed. Conclusion: BG hamartoma may be a rare indication for surgery.
References
1.
Peison B, Benisch B: Brunner’s gland adenoma of the duodenal bulb. Am J Gastroenterol 1982;77:276–278.
2.
Levine JA, Burgart LJ, Batts KP, Wang KK: Brunner’s gland hamartomas: clinical presentation and pathological features of 27 cases. Am J Gastroenterol 1995;90:290–294.
3.
Rocco A, Borriello P, Compare D, De Colibus P, Pica L, Iacono A, Nardone G: Large Brunner’s gland adenoma: case report and literature review. World J Gastroenterol 2006;12:1966–1968.
4.
Mumtaz R, Shah IA, Ramirez FC: Brunner’s gland hamartoma simulating a pancreatic mass with duodenal obstruction. Gastrointest Endosc 2002;56:932–934.
5.
Pricolo VE, Lee KC, Van Zuiden PE, Vezeridis MP: Brunner’s gland adenoma. South Med J 1987;80:1572–1574.
6.
Block KP, Frick TJ, Warner TFSC: Gastrointestinal bleeding from a Brunner’s gland hamartoma: characterization by endoscopy, computed tomography, and endoscopic ultrasound. Am J Gastroenterol 2000;95:1581–1583.
7.
Gill SS, Heuman DM, Mihas AA: Small intestinal neoplasms. J Clin Gastroenterol 2001;33:267–282.
8.
Buckley JA, Jones B, Fishman EK: Small bowel cancer. Imaging features and staging. Radiol Clin North Am 1997;35:381–402.
9.
Perez A, Saltzman JR, Carr-Locke DL, Brooks DC, Osteen RT, Zinner MJ, Ashley SW, Whang EE: Benign nonampullary duodenal neoplasms. J Gastrointest Surg 2003;7:536–541.
10.
Fujimaki E, Nakamura S, Sugai T, Takeda Y: Brunner’s gland adenoma with a focus of p53-positive atypical glands. J Gastroenterol 2000;35:155–158.
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.